Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure. METHODS: After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained. RESULTS: Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (-21+/-16 vs. -2+/-18 per hour, P<0.001) and in norepinephrine levels (-1.03+/-1.84 vs. 0.02+/-0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6+/-2.8 percent vs. 0.4+/-2.5 percent, P<0.001), ejection fraction (2.2+/-5.4 percent vs. 0.4+/-5.3 percent, P=0.02), and the distance walked in six minutes (20.0+/-55 vs. -0.8+/-64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54). CONCLUSIONS: Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically a high loop gain can express itself as periodic breathing, for example, at high altitude,357 or in congestive heart failure (CHF).358,359”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [359]
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
EEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Research works printed but not linked: 4
- Bradley TD, 2001, Can J Cardiol, 17, 677
- Staats BA, 1984, Am Rev Respir Dis, 130, 59
- Johnstone DE, 1994, Can J Cardiol, 10, 613
- 10.1172/jci21748 · doi:10.1172/jci21748 · Paper page
Cited by
Items 601–700 of 1,000
Is sleep apnoea a specialist condition? The role of general practitioners
Martínez‐García, M. Á., & Catalán, P. (2010) · Breathe · doi:10.1183/20734735.009210 · Cited by 8
“Although CPAP does not appear to improve mortality in patients with heart failure and central sleep apnoea (Cheyne–Stokes breathing), it may be effective in the evolution of patients predominantly subject to obstructive events [22].”
BackgroundObstructive Sleep Apnea: A Cardiopulmonary Perspective and Medical Therapeutics
Jalandhara, N., Patel, A. N., Arora, R. R., & Jalandhara, P. (2009) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181788cdf · Cited by 8
“These devices are excellent alternative to surgery and currently the mainstay of treatment of OSA as there is definitive evidence showing improvement in cardiovascular morbidity and mortality.(23,31) Tracheotomy is reserved for patients with severe OSA and cardiorespiratory compromise in whom positive airway pressure…”
BackgroundMethodInfluentialSleep physiology, abnormal States, and therapeutic interventions.
Wickboldt, A. T., Bowen, A. F., Kaye, A. J., Kaye, A. M., Bueno, F. R., & Kaye, A. D. (2012) · Europe PMC (PubMed Central) · Cited by 12
A review of preventing central sleep apnea by inspired CO 2
Mulchrone, A. M., Shokoueinejad, M., & Webster, J. G. (2016) · Physiological Measurement · doi:10.1088/0967-3334/37/5/r36 · Cited by 8
Introduction to Modern Sleep Technology
Chiang, R. P., & Kang, S.-C. (2012) · International series on intelligent systems, control and automation: science and engineering · doi:10.1007/978-94-007-5470-6 · Cited by 9
Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure
Floras, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10016-6 · Cited by 10
Self-citationXie, J., Covassin, N., Chahal, C. A. A., Schulte, P. J., Singh, P., Somers, V. K., & Caples, S. M. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.11.014 · Cited by 8
Iftikhar, I. H., & Khayat, R. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02512-y · Cited by 8
Ishiwata, S., Kasai, T., Sato, A., Suda, S., Matsumoto, H., Shitara, J., Yatsu, S., Murata, A., Shimizu, M., Kato, T., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01969-x · Cited by 9
“However, to the best of our knowledge, there are no adequately powered randomized controlled studies on the beneficial effects of SDB treatment with CPAP on mortality and/or rehospitalization [24].”
BackgroundKaravidas, A. I., Kapsimalis, F., Lazaros, G. A., Markozannes, E., Arapi, S. M., Cholidou, K., Matzaraki, V., Kyrkou, K., Tsiachris, D., Matsakas, E., et al. (2010) · Sleep And Breathing · doi:10.1007/s11325-010-0425-5 · Cited by 9
Noninvasive Positive Pressure Ventilation in Chronic Heart Failure
Jiang, H., Han, Y., Xu, C., Pu, J., & He, B. (2016) · Canadian Respiratory Journal · doi:10.1155/2016/3915237 · Cited by 8
“Forty percent to half of patients with chronic heart failure (CHF) and impaired left ventricular function go on to develop sleep-disordered breathing (SDB), either obstructive or central sleep apnea (OSA or CSA) [6–9], both of which disrupt the normal relaxing effects of sleep on the cardiovascular system.”
InfluentialMeta-analysis of Usefulness of Phrenic Nerve Stimulation in Central Sleep Apnea
Luni, F. K., Daniels, J. D., Link, M. S., Joglar, J. A., Zungsontiporn, N., Wu, R., Kaplish, N., & Malik, S. A. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.02.012 · Cited by 9
Dvir, H., Guo, S. X., Havlin, S., Ni, X., Tai, J., Li, D., Zhifei, X., Kang, R., & Bartsch, R. P. (2020) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2020.2979287 · Cited by 11
“While the origins of OSA are well understood, the mechanisms leading to CSA have not been fully described yet [4], although CSA is very common in elderly subjects and present in approximately 25% to 40% of patients with chronic heart failure [5].”
BackgroundMalhotra, A., Benjafield, A., Cistulli, P. A., Li, J., Woehrle, H., Armitstead, J. P., Sterling, K. L., Nuñez, C. M., Pépin, J., & on behalf of the medXcloud group (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9430 · Cited by 8
CPAP Should Be Used for Central Sleep Apnea in Congestive Heart Failure Patients
Bradley, T. D. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26652 · Cited by 8
Self-citationSleep apnoea in acute heart failure: fluid in flux
Floras, J. S., & Bradley, T. D. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv084 · Cited by 8
“largest randomized clinical trial published to date demonstrated no beneficial effect of CPAP on heart transplant-free survival.(13) Post-”
BackgroundSelf-citationSleep-disordered breathing: how should we judge its severity?
Cowie, M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv691 · Cited by 8
The Management of Co-Morbidities in Patients with Heart Failure – Central Sleep Apnoea
Coats, A. J. S., Shewan, L. G., & Abraham, W. T. (2017) · International Cardiovascular Forum Journal · doi:10.17987/icfj.v10i0.456 · Cited by 7
“This trial was stopped early due to slow enrollment and safety concerns as the treatment group initially had a higher mortality than the treatment group.[38] However, over time, no difference in morbidity or mortality was seen.”
BackgroundZentrale Schlafapnoe –Pathophysiologie, Relevanz, Diagnostik und Therapie
Schäfer, T., Schläfke, M. E., Westhoff, M., Duchna, H. W., Penzel, T., Scholle, S., Orth, M., & in Zusammenarbeit mit der Arbeitsgruppe Pathophysiologie von Schlaf und Atmung der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin, D. (2008) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-008-0350-z · Cited by 9
Grayburn, R., Kaka, Y., & Tang, W. H. W. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0322-5 · Cited by 8
New modalities for non-invasive ventilation
Simonds, A. K., & Hare, A. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-6-s41 · Cited by 8
Tsai, E. J., Wilkoff, B. L., Mitchell, J. E., Peterson, P. N., Riegel, B. J., Sam, F., Kasper, E. K., Levy, W. C., Masoudi, F. A., McBride, P. E., et al. (2013) · Cited by 7
Factors predisposing to worsening of sleep apnea in response to fluid overload in men
Gavrilović, B., Bradley, T. D., Vena, D., Lyons, O. D., Gabriel, J. M., Popović, M. R., & Yadollahi, A. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2016.05.003 · Cited by 10
Self-citationCheyne-stokes respiration during wakefulness in patients with chronic heart failure
Grimm, W., Kesper, K., Cassel, W., Timmesfeld, N., Hildebrandt, O., & Koehler, U. (2016) · Sleep And Breathing · doi:10.1007/s11325-016-1433-x · Cited by 9
Rehabilitation of Cardiovascular Disorders and Sleep Apnea
Jafari, B. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.01.001 · Cited by 7
“In contrast, studies in patients with HF and CSA suggested that CPAP also can improve EF(131,134) but does not show any survival benefit.(134) A recent randomized controlled trial (Adaptive Servo Ventilation in Patients with Heart Failure [SERVE-HF]) examined the effect of adaptive servoventilation in patients with re…”
ResultChokroverty, S., & Avidan, A. Y. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00093-1 · Cited by 7
Lo, S., Mbanze, I., Orr, J. E., DeYoung, P. N., Checkoway, H., Govo, V., Jessen, N., Damasceno, A., & Malhotra, A. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10510 · Cited by 7
Karimi, M., Hedner, J. A., & Grote, L. (2023) · Sleep Medicine · doi:10.1016/j.sleep.2023.04.025 · Cited by 7
Adaptive Servoventilation in Central Sleep Apnea
Randerath, W. J., & Javaheri, S. (2014) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2013.11.001 · Cited by 7
Sleep and Pulmonary Hypertension
Krishnan, V., & Collop, N. A. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2006.11.010 · Cited by 7
Sleep-Related Breathing Disorders in the Elderly
Stone, K. L., & Redline, S. S. (2006) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2006.04.003 · Cited by 8
Shalaby, A. A., Atwood, C. W., Selzer, F., Suffoletto, M. S., Gorcsan, J., & Strollo, P. J. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.03015.x · Cited by 9
Mallamaci, F., & Tripepi, G. L. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr196 · Cited by 7
“In the Canadian study [9], the hypopnoea apnoea index (AHI), which is a well known and most used index of SA, measured after a long dialysis interval fell dramatically after 6 weeks of nocturnal haemodialysis and this improvement of the AHI was evident both on the dialysis day and in the day off dialysis.”
BackgroundRanderath, W. J., & Herkenrath, S. D. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.02.002 · Cited by 7
“increased survival rates in large, prospective, randomized studies so far.(44,59) Although the Canadian Continuous Positive Airway Pressure (CanPAP) trial showed that CPAP improved apneas and hypopneas, oxygen saturation, ejection fraction, norepinephrine levels, and exercise performance over a mean of 2 years, it fai…”
Carmo, J., Araújo, I., Marquês, F., & Fonseca, C. (2017) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2017.06.007 · Cited by 10
“Ao fim de dois anos de seguimento, não se registaram diferenc¸as significativas no objetivo primário do estudo (número de hospitalizac¸ões, mortalidade ou transplante) 67 (tabela 2).”
BackgroundA review on the treatment of Cheyne Stokes Breathing in patients with congestive heart failure
Mittal, N., Sykes, A. V., & Malhotra, A. (2023) · Sleep And Breathing · doi:10.1007/s11325-023-02790-8 · Cited by 7
“Treatment of CSA with CPAP was tested in the CANPAP study in NEJM in which no benefit was observed [2].”
MethodKuźniar, T. J., & Kasibowska-Kuźniar, K. (2011) · Disease-a-Month · doi:10.1016/j.disamonth.2011.06.002 · Cited by 8
Baliga, R. R., Dec, G. W., & Narula, J. (2013) · Global Heart · doi:10.1016/j.gheart.2013.05.002 · Cited by 7
Noninvasive ventilation improves cardiac function in patients with chronic heart failure
Cheng, J., Liu, Y., Li, G., Zhang, Z., Ma, L., Yang, X., Yang, J., Zhang, K., Kong, J., Dong, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10441 · Cited by 7
“Only 23 reports of studies with suitable data were eligible for inclusion, all of which were full articles published in English from 1997 to 2015 [3, 10-31].”
BackgroundA retrospective analysis of cardiovascular outcomes in patients treated with ASV
Hetland, A., Haugaa, K. H., Vistnes, M., Liland, K. H., Olseng, M., Jacobsen, M., & Edvardsen, T. (2016) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2016.1262546 · Cited by 8
“[24] A large randomized sleep study, The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial (CANPAP),[11] found that CPAP had no effect on heart transplant-free survival.”
BackgroundSleep-disordered breathing in heart failure: The state of the art after the SERVE-HF trial
Carmo, J., Araújo, I., Marquês, F., & Fonseca, C. (2017) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2017.06.008 · Cited by 7
“After a mean follow-up of two years, no significant differences were found in the primary outcome of death from all causes and heart transplantation (Table 2).(67) It should be noted that CPAP had only a weak effect on CSA in this trial, reducing mean AHI to 19/h, which was more than the 15/h inclusion criterion.”
BackgroundVariability in hypoxic response: Could genetics play a role?
Simonson, T. S., & Malhotra, A. (2020) · The Journal of Physiology · doi:10.1113/jp279590 · Cited by 7
“Similarly, patients with congestive heart failure can develop Cheyne Stokes breathing (CSB), which has been somewhat controversial as a result of uncertainty about its prognostic impact and its optimal therapy (Bradley et al. 2005).”
BackgroundPrevalence and management of central sleep apnea in heart failure patients
Mookadam, F., Calvin, A. D., & Somers, V. K. (2008) · Current Heart Failure Reports · doi:10.1007/s11897-008-0035-8 · Cited by 9
(2008) · Oxford University Press eBooks · doi:10.1093/med/9780199542338.001.0001 · Cited by 7
PAP and Cardiovascular Events in Adults With Sleep Apnea: Is PAP Useful?
Mansukhani, M. P., Somers, V. K., & Shafazand, S. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6858 · Cited by 6
Heart failure – what’s new and what’s changed?
Callan, P., & Clark, A. L. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-6-s37 · Cited by 6
Management of central sleep apnoea: a review of non-hypercapnic causes
Zheng, Y., Tai, J. E., & Yee, B. J. (2024) · Breathe · doi:10.1183/20734735.0235-2023 · Cited by 8
Yogasundaram, H., & Oudit, G. Y. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.07.712 · Cited by 6
Goldberg, L. R., Fox, H., Stellbrink, C., Bozkurt, B., BOEHMER, J. P., Mora, J. I., Doshi, R. N., Morgenthaler, T. I., Levy, W. C., Meyer, T. E., et al. (2022) · Sleep Medicine · doi:10.1016/j.sleep.2022.08.026 · Cited by 6
Enhanced expiratory rebreathing space for high loop gain sleep apnea treatment
Quinn, T., THOMAS, R. J., & Heckman, E. J. (2023) · Frontiers in Sleep · doi:10.3389/frsle.2023.1248371 · Cited by 8
Pinna, G. D., Maestri, R., Robbi, E., Guazzotti, G., Caporotondi, A., & Rovere, M. T. L. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.06.011 · Cited by 6
Central Sleep Apnea, Hypoventilation Syndromes and Periodic Breathing Disorders
Caples, S. M., & Somers, V. K. (2006) · KARGER eBooks · doi:10.1159/000093167 · Cited by 7
Efeitos da pressão positiva contínua nas vias aéreas na insuficiência cardíaca crônica
de Azevedo, J. C. M., de Carvalho, E. R. M., Feijó, L. A., de Oliveira, F. P., de Menezes, S. L. S., & Murad, H. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010005000068 · Cited by 6
A novel therapeutic approach for the treatment of central sleep apnea: The remedē® system
Germany, R. E., Joseph, S. M., James, K. J., & Kao, A. C. (2014) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2014.03.007 · Cited by 6
“term improvement in morbidity or mortality except in patients who had optimum treatment of CSA with CPAP [27,28].”
BackgroundSleep Apnea and Left Atrial Phasic Function in Heart Failure With Reduced Ejection Fraction
Haruki, N., Tsang, W., Thavendiranathan, P., Woo, A., TOMLINSON, G. A., Logan, A. G., Bradley, T. D., & Floras, J. S. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.047 · Cited by 6
“Subjects with an AHI 15 with 50% events of obstructive origin were classified as having OSA, whereas subjects with an AHI 15 with > 50% events of central origin were classified as having CSA.24 The oxygen desaturation index was quantified as the number of dips in arterial oxyhemoglobin saturation of 3% per hour of sle…”
BackgroundSelf-citationDyken, M. E., Yamada, T., & Ali, M. (2008) · CRC Press eBooks · doi:10.3109/9781420019926-24 · Cited by 8
Obstructive Sleep-Disordered Breathing Is More Common than Central in Mild Familial Dysautonomia
Hilz, M. J., Moeller, S., Buechner, S., Czarkowska, H., Ayappa, I. A., Axelrod, F. B., & Rapoport, D. M. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6342 · Cited by 6
Bussoni, M. F., Guirado, G. N., Matsubara, L. S., Roscani, M. G., Polegato, B. F., Minamoto, S. T., Bazan, S. G. Z., & Matsubara, B. B. (2014) · Clinics · doi:10.6061/clinics/2014(05)010 · Cited by 6
Future of Sleep-Disordered Breathing Therapy Using a Mechanistic Approach
Jen, R., Grandner, M. A., & Malhotra, A. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.007 · Cited by 7
“For patients with residual CSB despite maximal cardiac treatment, nasal CPAP may be helpful by reducing cardiac preload and afterload, although positive outcome data are lacking.(93) Adaptive servoventilation (ASV) is similar to CPAP, except that it automatically adjusts pressure support based on monitoring of ventila…”
Sleep Quality, Anxiety, and Depression in Patients With Heart Failure
Aria, H., & Naghizadeh, M. M. (2019) · Journal of Advanced Medical Sciences and Applied Technologies · doi:10.32598/jamsat.3.4.213 · Cited by 8
“Furthermore drugs used to treat CHF and cardiac resynchronization therapy are partially effective in the treatment of Central Sleep Apnea (CSA) or Cheyne Stokes Respiration (CSR) [20, 21].”
Heart failure guidelines: What you need to know about the 2017 focused update
Haselhuhn, L. R., Brotman, D. J., & Wittstein, I. S. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.18022 · Cited by 6
Hernández, A. V., Jeon, A., Denegri‐Galvan, J., Ortega-Loayza, F., Felix-Moscoso, M., Pasupuleti, V., & Kaw, R. K. (2019) · Sleep And Breathing · doi:10.1007/s11325-019-01882-8 · Cited by 7
Obstructive sleep apnea versus central sleep apnea: prognosis in systolic heart failure
Hetland, A., Vistnes, M., Haugaa, K. H., Liland, K. H., Olseng, M., & Edvardsen, T. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2020.03.02 · Cited by 8
“Though PAP treatment remains standard treatment in OSA, this treatment is of limited use in CHF with CSR and reduced systolic function (29,30).”
MethodSleep Breathing Disorders in Heart Failure
Coniglio, A. C., & Mentz, R. J. (2022) · Cardiology Clinics · doi:10.1016/j.ccl.2021.12.006 · Cited by 12
Oldenburg, O., Bitter, T., Fox, H., & Horstkotte, D. (2014) · Somnologie - Schlafforschung und Schlafmedizin · doi:10.1007/s11818-013-0652-7 · Cited by 6
Sleep Apnea-Hypopnea Syndrome and the Heart
Santos, J. T., Álvarez, M. L. A., Guevara, J. C., Azcárate, J. M. A., & Canal, J. M. M. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60030-9 · Cited by 7
Jaffuel, D., Combes, N., & Jaber, S. (2013) · CHEST Journal · doi:10.1378/chest.13-0209 · Cited by 6
Treating Central Sleep Apnoea in Heart Failure: Is Pull Better Than Push?
Cowie, M., Gallagher, A. M., & Simonds, A. K. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1337 · Cited by 6
Seek and Treat Obstructive Sleep Apnea in Heart Failure
Jemtel, T. H. L., & Jelić, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.049 · Cited by 6
Épidémiologie, populations à risque et phénotypes cliniques du syndrome d’apnées du sommeil
Heinzer, R. C. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.11.002 · Cited by 9
Azarbarzin, A., Esmaeili, N., Vena, D., Messineo, L., Redline, S. S., McKane, S. W., Wellman, A., Javaheri, S., & Sands, S. A. (2025) · SLEEP · doi:10.1093/sleep/zsaf085 · Cited by 5
Kardiale Auswirkungen der obstruktiven Schlafapnoe
Steiner, S., & Willinghöfer, R. (2010) · Der Internist · doi:10.1007/s00108-010-2606-5 · Cited by 6
Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF
Abraham, W. T., Pleister, A. P., & Germany, R. E. (2018) · Cardiac failure review · doi:10.15420/cfr.2018:9:1 · Cited by 6
Trials of Bilevel Positive Airway Pressure—Spontaneous in Patients with Complex Sleep Apnoea
Kuźniar, T. J., Kasibowska-Kuźniar, K., & Freedom, T. (2012) · Advances in respiratory medicine · doi:10.5603/arm.27586 · Cited by 5
Kundel, V., Devarakonda, K., Khan, S., Suárez‐Fariñas, M., Cohen, O. S., Santos‐Gallego, C. G., Menegus, M. A., Kini, A. S., Vengrenyuk, Y., Okamoto, N., et al. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s489788 · Cited by 5
“63 In fact, a 2015 study showed an increase in cardiovascular mortality among patients with CSA on specialized PAP therapy (adaptive servo ventilation) despite improvements in nocturnal oxygen saturation, 64 though a more recent study reported conflicting findings with no effect on mortality.”
Sleep and Cardiovascular Disease
Gupta, S. K., & Arnedt, J. T. (2011) · Wiley eBooks · doi:10.1002/9780470975138.ch11 · Cited by 6
Circadian variations in blood pressure in health and disease: implications for patient management
Slaughter, M. S., Chugh, & Loughran (2011) · ChronoPhysiology and Therapy · doi:10.2147/cpt.s15597 · Cited by 6
“subjects with adequate diminution of nocturnal apneic episodes (apnea-hypopnea index , 15).(107) Similarly, the use of CPAP therapy has been associated with improved circadian blood pressure architecture.”
Morbidity and Predicted Mortality in Older Adults with Central Sleep Apnea
Onen, H. (2013) · Journal of Sleep Disorders & Therapy · doi:10.4172/2167-0277.1000146 · Cited by 5
“Patients were considered to have CSA or OSA if more than 50 percent of the events determined were central or obstructive events, respectively [7].”
BackgroundCheyne-Stokes respiration in patients with heart failure: ominous sign or innocent bystander?
Brack, T. (2007) · Swiss Medical Weekly · doi:10.4414/smw.2007.11675 · Cited by 5
“On the basis of these results, a large randomised multicenter trial comprising 258 patients with heart failure and CSR was performed in Canada (CANPAP) [ 61 ] in which 128 patients were treated with CPAP and compared with 130 matched patients without CPAP therapy.”
BackgroundMethodPeker, Y., & Strollo, P. J. (2017) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2017-110835 · Cited by 5
Central and Mixed Sleep-Related Breathing Disorders
Randerath, W. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1703-7.10019-2 · Cited by 6
Comparative Evaluation of Therapeutic Approaches to Central Sleep Apnea
Raeisi, A., Sadeghi, Y., Sedaghat, M., Majedi, M., Pakzad, B., & Ghaderi, A. (2019) · Advanced Biomedical Research · doi:10.4103/abr.abr_173_18 · Cited by 5
“There are various therapeutic options, for example, using positive airway pressure (PAP) devices, including continuous PAP (CPAP),[6,7] bi‐level PAP therapy (BIPAP),[8,9] and adaptive servoventilation (ASV),[10,11] or applying supplemental O2, [12,13] carbon dioxide,[14,15] and/or pharmacologic agents.”
Holfinger, S. J., Chan, L., & Donald, R. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00506-1 · Cited by 5
Optimal NIV Medicare Access Promotion: Patients With Central Sleep Apnea
Morgenthaler, T. I., Malhotra, A., Berry, R. B., Johnson, K. G., Raphaelson, M. I., Gay, P. C., Owens, R. L., Wolfe, L. F., Benditt, J. O., Aboussouan, L. S., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.07.039 · Cited by 6
Yasuma, F., Tanahashi, T., Mori, T., Shimizu, Y., & Murohara, T. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.9387 · Cited by 5
“(20), there are two distinct groups of CHF patients with CSR: those who respond to CPAP therapy and those who do not.”
BackgroundShould All Congestive Heart Failure Patients Have a Routine Sleep Apnea Screening? Con
Li, Y., Daniels, L. B., Strollo, P. J., & Malhotra, A. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.04.013 · Cited by 7
Castriotta, R. J., & Majid, R. (2013) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2013.07.006 · Cited by 5
Sleep Disturbances in General Medical Disorders
Chokroverty, S. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6578-6_47 · Cited by 5
Kahwash, R., & Khayat, R. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2017.01.002 · Cited by 5
Voderholzer, U., & Guilleminault, C. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00031-0 · Cited by 8
Cardiovascular Disease and Sleep
Matsumoto, H., & Kasai, T. (2017) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.63.435 · Cited by 6
Severe OSA Leading to Long Pauses in 24-h Holter ECG Reversed with CPAP
Mukhopadhyay, M., Roy, S., Bera, M., & Bhattacharya, G. (2019) · Current Cardiology Reviews · doi:10.2174/1573403x15666191210115404 · Cited by 5
Increased heart rate with sleep disordered breathing in hypertrophic cardiomyopathy
Konečný, T., Khoo, M. C. K., Covassin, N., Edelhofer, P., Bukartyk, J., Park, J. Y., Venkataraman, S., Karim, S., Chahal, C. A. A., Kára, T., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.08.020 · Cited by 5
Abnormal Sleep-Related Breathing Related to Heart Failure
Singh, T. D. (2022) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2021.10.007 · Cited by 5
Obstructive sleep apnea in women: We can do more and better
Martínez‐García, M. Á., Sierra-Párraga, J. M., & García-Ortega, A. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101645 · Cited by 5
Nicklas, J. M., Bleske, B. E., Harrison, R. V., Hogikyan, R. V., Kwok, Y. S., & Chavey, W. E. (2013) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2012.11.010 · Cited by 6
“The largest reported study demonstrated that continuous positive airway pressure decreased the degree of disordered breathing and marginally improved exercise capacity, but did not alter mortality or the need for heart transplantation.(117)”
Long-term Efficacy of Acetazolamide on Cheyne-Stokes Respiration in Congestive Heart Failure
Javaheri, S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.174.4.479a · Cited by 5
Diagnosis and treatment of sleep apnea in heart disease
Barcena, J. A., & Fang, J. C. (2007) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-007-0045-y · Cited by 7
Obstructive sleep apnea and heart failure
Calvin, A. D., Albuquerque, F. N., Adachi, T., & Somers, V. K. (2009) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-009-0047-z · Cited by 7
Autonomic Abnormalities in Congestive Heart Failure Patients With Sleep-Disordered Breathing
Ng, A. C. C., Freedman, S. B., & Sindone, A. P. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.02.003 · Cited by 5
Metadata
- Authors
- Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., & Floras, J. S.
- Affiliations
- University of Toronto (CA)
- McGill University (CA)
- Université Laval (CA)
- Dalhousie University (CA)
- Western University (CA)
- University of Calgary (CA)
- University of Regensburg (DE)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2025-2033
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130637800
- Semantic Scholar
- 266ff6f4028ab04f061c1b59c2a17a2fc2990e32
- Cited by
- 1,189
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 33 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 55 · 2018: 50 · 2017: 70 · 2016: 87 · 2015: 68 · 2014: 44 · 2013: 67 · 2012: 62
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- continuous positive airway pressure, central sleep apnea, heart failure, nocturnal oxygen saturation, norepinephrine, ejection fraction, exercise capacity, neurohormones, atrial natriuretic peptide, quality of life, heart transplantation, sleep-disordered breathing, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Aged, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Norepinephrine, Stroke Volume, Survival Rate, Proportional Hazards Models, Heart Transplantation, Treatment Outcome, Exercise Tolerance, Sleep Apnea, Central, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.